Mandate

Vinge advises Industrifonden in connection with an investment in Cellevate

July 03, 2023 M&A

Vinge has advised Industrifonden in connection with its investment in Cellevate. Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

Vinge’s team primarily consisted of Johan Larsson, Ellinor Wargenbrant and Stojan Arnerstål

Related

Vinge advises on the sale of Compab to Tången

Vinge has advised the owners of Compab Energiteknik in connection with the sale of 80 per cent of the shares to Tången Industrikapital. Compab, which has a turnover of approximately SEK 100 million, sells, installs and services, amongst other things, steam and hot-water boilers as well as burners for the industrial sector.
October 26, 2026

Vinge advises Capio on the acquisition of Rehabhotellet Sthlm AB

Rehabhotellet i Sthlm AB provides advanced home healthcare and specialized inpatient palliative care within the Stockholm Region.
October 26, 2026

Vinge has advised AIP Management on the acquisition of the Överturingen wind farm

Vinge has advised AIP Management, an investor specialising in energy and climate transition infrastructure, in connection with the acquisition of an onshore wind farm in Överturingen in central Sweden.
October 22, 2026